Search the Appendices of Resolution CM/Res(2018)1
2309 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
DAROLUTAMIDE | L02BB06 | IT | I | 22-12-2020 | EMEA/H/C/004790 | 27-03-2020 | VALID | |
ANASTROZOLE | L02BG03 | IT | II | IT/H/0271/001/ | 03-03-2015 | VALID | ||
LETROZOLE | L02BG04 | IT | II | IT/H/0177/001 | 06-02-2015 | VALID | ||
EXEMESTANE | L02BG06 | IT | II | 07-11-2016 | None | VALID | ||
ABARELIX | L02BX01 | IT | Not authorised | VALID | ||||
ABIRATERONE | L02BX03 | IT | I | None | VALID | |||
RELUGOLIX | L02BX04 | IT | I | 18-11-2022 | EMEA/H/C/005353 | 29-04-2022 | VALID | |
FILGRASTIM | L03AA02 | IT | II | None | 16-09-2003 | VALID | ||
MOLGRAMOSTIM | L03AA03 | IT | I | None | 16-09-2003 | VALID | ||
PEGFILGRASTIM | L03AA13 | IT | POM | VALID | ||||
LIPEGFILGRASTIM | L03AA14 | IT | POM | 14-05-2018 | VALID | |||
INTERFERON ALFA NATURAL | L03AB01 | IT | II | None | 16-09-2003 | VALID | ||
INTERFERON GAMMA | L03AB03 | IT | I | None | 16-09-2003 | VALID | ||
INTERFERON ALFA-2A | L03AB04 | IT | II | None | 16-09-2003 | VALID | ||
PEGINTERFERON ALFA-2A | L03AB11 | IT | II | None | VALID | |||
ROPEGINTERFERON ALFA-2B | L03AB15 | IT | I | 07-10-2020 | VALID | |||
ALDESLEUKIN | L03AC01 | IT | I | VALID | ||||
BCG VACCINE | L03AX03 | IT | I | None | 16-09-2003 | VALID | ||
PIDOTIMOD | L03AX05 | IT | II | None | 16-09-2003 | VALID | ||
THYMOPENTIN | L03AX09 | IT | II | None | 16-09-2003 | VALID | ||
GLATIRAMER ACETATE | L03AX13 | IT | II | VALID | ||||
ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) | L04AA04 | IT | POM | VALID | ||||
MYCOPHENOLIC ACID | L04AA06 | IT | I | VALID | ||||
ABATACEPT | L04AA24 | IT | I | 07-11-2019 | VALID | |||
CLADRIBINE | L04AA40 | IT | I | 21-02-2020 | VALID | |||
IMLIFIDASE | L04AA41 | IT | I | VALID | ||||
EFGARTIGIMOD ALFA | L04AA58 | IT | I | 18-11-2022 | EMEA/H/C/005849 | 10-08-2022 | VALID | |
ETANERCEPT | L04AB01 | IT | II | VALID | ||||
INFLIXIMAB | L04AB02 | IT | I | VALID | ||||
ADALIMUMAB | L04AB04 | IT | II | 12-07-2022 | VALID | |||
CERTOLIZUMAB PEGOL | L04AB05 | IT | II | VALID | ||||
GOLIMUMAB | L04AB06 | IT | II | VALID | ||||
DACLIZUMAB | L04AC01 | IT | Not authorised | VALID | ||||
ANAKINRA | L04AC03 | IT | II | 28-11-2019 | VALID | |||
SECUKINUMAB | L04AC10 | IT | II | VALID | ||||
IXEKIZUMAB | L04AC13 | IT | POM | 07-11-2016 | EMEA/H/C/003943 | 25-04-2016 | VALID | |
GUSELKUMAB | L04AC16 | IT | I | 04-05-2018 | VALID | |||
TILDRAKIZUMAB | L04AC17 | IT | Not authorised | 15-11-2018 | VALID | |||
RISANKIZUMAB | L04AC18 | IT | I | 23-01-2020 | VALID | |||
SATRALIZUMAB | L04AC19 | IT | I | 19-10-2021 | EMEA/H/C/004788 | 24-06-2021 | VALID | |
BIMEKIZUMAB | L04AC21 | IT | I | 19-10-2021 | EMEA/H/C/005316 | 20-08-2021 | VALID | |
SPESOLIMAB | L04AC22 | IT | I | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
MIRIKIZUMAB | L04AC24 | IT | I | 14-11-2023 | EMEA/H/C/005122 | 26-05-2023 | VALID | |
CICLOSPORIN | L04AD01 | IT | I | VALID | ||||
TACROLIMUS | L04AD02 | IT | I | VALID | ||||
VOCLOSPORIN | L04AD03 | IT | I | 18-11-2022 | EMEA/H/C/005256 | 15-09-2022 | VALID | |
FINGOLIMOD | L04AE01 | IT | II | 07-09-2020 | VALID | |||
OZANIMOD | L04AE02 | IT | I | VALID | ||||
SIPONIMOD | L04AE03 | IT | I | 05-06-2020 | EMEA/H/C/004712 | 13-01-2020 | VALID | |
PONESIMOD | L04AE04 | IT | I | 19-10-2021 | EMEA/H/C/005163 | 19-05-2021 | VALID |